Overview Financials News + Filings Key Docs Charts Ownership Insiders |
Inhibrx, Inc. (INBX)
|
Add to portfolio |
|
|
Price: |
$39.46
| | Metrics |
OS: |
43.7
|
M
| |
|
|
Market cap: |
$1.72
|
B
| |
|
|
Net debt:
|
$12
|
M
| |
|
|
EV:
|
$1.74
|
B
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
($149)
|
M
| |
|
|
EBIT
|
($151)
|
M
| |
|
|
EPS |
($4.12)
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
Revenues | 2.2 | 7.2 | 12.9 | 13.2 | 33.5 | 25.5 |
Revenue growth | -69.7% | -43.9% | -2.4% | -60.5% | 31.1% | |
Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 58.3 | 25.5 |
Gross profit | 2.2 | 7.2 | 12.9 | 13.2 | -24.9 | 0.0 |
Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | -74.3% | 0.0% |
Research and development | 110.2 | 71.4 | 73.5 | 47.9 | | |
General and administrative | 21.1 | 12.4 | 6.8 | 6.3 | 4.7 | 2.6 |
EBIT | -129.1 | -76.6 | -67.9 | -43.7 | -29.5 | -19.7 |
EBIT margin | -5890.4% | -1058.8% | -527.1% | -330.9% | -88.2% | -77.3% |
Pre-tax income | -145.2 | -81.8 | -75.6 | -50.5 | -30.9 | -21.8 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.9 | 0.1 | 0.3 |
Net income | -145.2 | -81.8 | -76.1 | -51.4 | -31.0 | -19.4 |
Net margin | -6625.3% | -1130.8% | -590.7% | -389.1% | -92.7% | -76.2% |
|
Diluted EPS | ($3.62) | ($2.15) | ($3.01) | ($2.83) | ($1.71) | ($0.62) |
Shares outstanding (diluted) | 40.1 | 38.0 | 25.3 | 18.2 | 18.2 | 31.6 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|